4,878 reports of this reaction
3.1% of all DALFAMPRIDINE reports
#5 most reported adverse reaction
BALANCE DISORDER is the #5 most commonly reported adverse reaction for DALFAMPRIDINE, manufactured by Merz Pharmaceuticals, LLC. There are 4,878 FDA adverse event reports linking DALFAMPRIDINE to BALANCE DISORDER. This represents approximately 3.1% of all 157,067 adverse event reports for this drug.
Patients taking DALFAMPRIDINE who experience balance disorder should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
BALANCE DISORDER is moderately reported among DALFAMPRIDINE users, representing a notable but not dominant share of adverse events.
In addition to balance disorder, the following adverse reactions have been reported for DALFAMPRIDINE:
The following drugs have also been linked to balance disorder in FDA adverse event reports:
BALANCE DISORDER has been reported as an adverse event in 4,878 FDA reports for DALFAMPRIDINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
BALANCE DISORDER accounts for approximately 3.1% of all adverse event reports for DALFAMPRIDINE, making it a notable side effect.
If you experience balance disorder while taking DALFAMPRIDINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.